Patent ID: 9506117
Filing Date: 2016-11-29
CPC Classification: C12Q,G01N

Claim Text:
1. A method for detectably labelling a set of gene products from a human biological sample comprising: contacting a cervical tumor sample from a subject with reagents for reverse transcribing at least three hypoxia profile gene products selected from the group consisting of ALDOA, AK2, AK3L1, B3GNT4, SCARB1, CLK3, C20ORF20, ECE2, ERO1L, GAPDH, HMOX1, ISG15, PFKFB4, P4HA2, PYGL, RPL36A, UPK1A, DDIT3, KCTD11, PVR, RHOC, STC2, C14ORF2, C19ORF53, C4ORF3, FGF11, SH3GL3, SNTA1, SPAG7, S100A2 and TRAPPC1, mRNA transcripts to provide complementary DNA; and b) amplifying said complementary DNA in the presence of a probe to provide detectably labeled amplified complementary DNA.